Seeking Alpha

Amgen (AMGN -0.7%) underperformed a little today after a U.S. appeals court gave a green light...

Amgen (AMGN -0.7%) underperformed a little today after a U.S. appeals court gave a green light to a securities class-action lawsuit accusing the company of failing to disclose safety information for two anemia drugs, and of promoting unauthorized uses of its products.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector